<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20250325061242
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20250325061242" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 25 Mar 2025 10:12:44 +0000</lastbuilddate>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Differences in Pediatric and Adult Heart Allocation Policies and Some of the Reasons Why</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):825-827. doi: 10.1161/CIRCULATIONAHA.125.072978. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127160</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.072978>10.1161/CIRCULATIONAHA.125.072978</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127160</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Ryan R Davies</dc:creator>
<dc:creator>Maryjane Farr</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Differences in Pediatric and Adult Heart Allocation Policies and Some of the Reasons Why</dc:title>
<dc:identifier>pmid:40127160</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.072978</dc:identifier>
</item>
<item>
<title>Letter by Xu et al Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127159/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):e765. doi: 10.1161/CIRCULATIONAHA.124.072061. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127159/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127159</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072061>10.1161/CIRCULATIONAHA.124.072061</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127159</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lingyu Xu</dc:creator>
<dc:creator>Yanfei Wang</dc:creator>
<dc:creator>Yan Xu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Xu et al Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</dc:title>
<dc:identifier>pmid:40127159</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072061</dc:identifier>
</item>
<item>
<title>Response by Zhao et al to Letters Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127158/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):e766. doi: 10.1161/CIRCULATIONAHA.125.073361. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127158/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127158</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073361>10.1161/CIRCULATIONAHA.125.073361</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127158</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Di Zhao</dc:creator>
<dc:creator>Eliseo Guallar</dc:creator>
<dc:creator>Bruce A Wasserman</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Zhao et al to Letters Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</dc:title>
<dc:identifier>pmid:40127158</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073361</dc:identifier>
</item>
<item>
<title>Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127157/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>Hypertension is the leading modifiable risk factor for atrial fibrillation (AF) and is estimated to be present in >;70% of AF patients. This Frontiers Review was prepared by 29 expert members of the AF-SCREEN International Collaboration to summarize existing evidence and knowledge gaps on links between hypertension, AF, and their cardiovascular sequelae; simultaneous screening for hypertension and AF; and the prevention of AF through antihypertensive therapy. Hypertension and AF are inextricably...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):863-877. doi: 10.1161/CIRCULATIONAHA.124.071047. Epub 2025 Mar 24.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Hypertension is the leading modifiable risk factor for atrial fibrillation (AF) and is estimated to be present in >;70% of AF patients. This Frontiers Review was prepared by 29 expert members of the AF-SCREEN International Collaboration to summarize existing evidence and knowledge gaps on links between hypertension, AF, and their cardiovascular sequelae; simultaneous screening for hypertension and AF; and the prevention of AF through antihypertensive therapy. Hypertension and AF are inextricably connected. Both are easily diagnosed, often silent, and frequently treated inadequately. Together, they additively increase the risk of ischemic stroke, heart failure, and many types of dementia, resulting in greater all-cause mortality, considerable disease burden, and increased health care expenditures. Automated upper arm cuff blood pressure devices with implemented technology can be used to simultaneously detect both hypertension and AF. However, positive screening for AF with an oscillometric blood pressure monitor still requires ECG confirmation. The current evidence suggests that high-risk individuals aged ≥65 years or with treatment-resistant hypertension could benefit from AF screening. Since antihypertensive therapy effectively lowers AF risk, particularly in individuals with left ventricular dysfunction, hypertension should be the key target for AF prediction and prevention rather than merely a comorbidity of AF. Nevertheless, several important gaps in knowledge need to be filled over the next years, including the ideal method and selection of patients for simultaneous screening of hypertension and AF and the optimal antihypertensive drug class and blood pressure targets for AF prevention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127157/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127157</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071047>10.1161/CIRCULATIONAHA.124.071047</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127157</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Teemu J Niiranen</dc:creator>
<dc:creator>Renate B Schnabel</dc:creator>
<dc:creator>Aletta E Schutte</dc:creator>
<dc:creator>Yitschak Biton</dc:creator>
<dc:creator>Giuseppe Boriani</dc:creator>
<dc:creator>Claire Buckley</dc:creator>
<dc:creator>Alan C Cameron</dc:creator>
<dc:creator>Albertino Damasceno</dc:creator>
<dc:creator>Søren Z Diederichsen</dc:creator>
<dc:creator>Wolfram Doehner</dc:creator>
<dc:creator>Yutao Guo</dc:creator>
<dc:creator>F D Richard Hobbs</dc:creator>
<dc:creator>Boyoung Joung</dc:creator>
<dc:creator>Graeme J Hankey</dc:creator>
<dc:creator>Gregory Y H Lip</dc:creator>
<dc:creator>Trudie Lobban</dc:creator>
<dc:creator>Maja-Lisa Løchen</dc:creator>
<dc:creator>Georges Mairesse</dc:creator>
<dc:creator>Amam Mbakwem</dc:creator>
<dc:creator>Peter A Noseworthy</dc:creator>
<dc:creator>George Ntaios</dc:creator>
<dc:creator>Steven Steinhubl</dc:creator>
<dc:creator>George Stergiou</dc:creator>
<dc:creator>Jesper Hastrup Svendsen</dc:creator>
<dc:creator>Robert G Tieleman</dc:creator>
<dc:creator>Jiguang Wang</dc:creator>
<dc:creator>Neil R Poulter</dc:creator>
<dc:creator>Jeff S Healey</dc:creator>
<dc:creator>Ben Freedman</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration</dc:title>
<dc:identifier>pmid:40127157</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071047</dc:identifier>
</item>
<item>
<title>Letter by Wei and Yu Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127156/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):e764. doi: 10.1161/CIRCULATIONAHA.124.071784. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127156/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127156</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071784>10.1161/CIRCULATIONAHA.124.071784</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127156</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Shouxin Wei</dc:creator>
<dc:creator>Sijia Yu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Wei and Yu Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</dc:title>
<dc:identifier>pmid:40127156</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071784</dc:identifier>
</item>
<item>
<title>Clinical Interpretation of Statistical Interaction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127155/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):811-813. doi: 10.1161/CIRCULATIONAHA.125.073644. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127155/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127155</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073644>10.1161/CIRCULATIONAHA.125.073644</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127155</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Andrea Bellavia</dc:creator>
<dc:creator>Sabina A Murphy</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Clinical Interpretation of Statistical Interaction</dc:title>
<dc:identifier>pmid:40127155</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073644</dc:identifier>
</item>
<item>
<title>Coupling Interval Counts in Ventricular Premature Depolarizations During Acute Ischemia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127154/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):884-886. doi: 10.1161/CIRCULATIONAHA.124.073654. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127154/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127154</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073654>10.1161/CIRCULATIONAHA.124.073654</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127154</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Yusuke Yamazaki</dc:creator>
<dc:creator>Hideo Mitamura</dc:creator>
<dc:creator>Toru Egashira</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Coupling Interval Counts in Ventricular Premature Depolarizations During Acute Ischemia</dc:title>
<dc:identifier>pmid:40127154</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073654</dc:identifier>
</item>
<item>
<title>Ganglionic Inflammation in a Patient With Takotsubo Syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127153/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):890-892. doi: 10.1161/CIRCULATIONAHA.124.070862. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127153/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127153</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070862>10.1161/CIRCULATIONAHA.124.070862</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127153</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Karin A Ziegler</dc:creator>
<dc:creator>Manuel Zeitler</dc:creator>
<dc:creator>Sandro Meunier</dc:creator>
<dc:creator>Inga Sinicina</dc:creator>
<dc:creator>Tim P Hasenbein</dc:creator>
<dc:creator>Daniel Andergassen</dc:creator>
<dc:creator>Anton Bomhard</dc:creator>
<dc:creator>Reginald V C T van der Kwast</dc:creator>
<dc:creator>Stefan Engelhardt</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Ganglionic Inflammation in a Patient With Takotsubo Syndrome</dc:title>
<dc:identifier>pmid:40127153</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070862</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127152/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):878-883. doi: 10.1161/CIRCULATIONAHA.125.074426. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127152/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40127152</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.074426>10.1161/CIRCULATIONAHA.125.074426</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127152</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:40127152</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.074426</dc:identifier>
</item>
<item>
<title>Homogeneity of the Coronary Microcirculation in Angina with Non-Obstructive Coronary Artery Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40126977/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: In most ANOCA patients, microvascular function is homogeneously distributed across the three major coronary territories. Single-artery testing may suffice in many cases, aligning with guidelines. However, some patients exhibit notable inter-territorial variation, suggesting that multivessel evaluation may be prudent in borderline scenarios.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 24:jeaf101. doi: 10.1093/ehjci/jeaf101. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: The homogeneity of coronary microcirculatory dysfunction (CMD) across different myocardial territories in angina with non-obstructive coronary artery disease (ANOCA) patients is scarcely explored. This study investigates the variability in microvascular resistance reserve (MRR) across the 3 main perfusion territories of the coronary circulation to investigate the homogeneity or dishomogeneity of microcirculatory function.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: This post-hoc analysis of the PACIFIC trials included symptomatic ANOCA patients with [15O]H2O positron emission tomography (PET) and three-vessel invasive fractional flow reserve (FFR). MRR was computed in the three main coronary branches by integrating PET-derived coronary flow reserve and invasive FFR. A total of 155 patients (50% male, age 59 ± 10 years) and 465 vessels (MRR: 3.92 ± 1.21) were included. There were no significant differences in MRR among the three coronary branches. Correlations in MRR among the three coronary branches were good (r = 0.76 to 0.86). The mean difference between MRR measurements in different arteries was small (2.4 to 7.5%), without any consistent directional bias. The overall intraclass correlation coefficient for absolute agreement was 0.80 (95% CI: 0.74-0.85), indicating good single-measure reliability. Approximately 80% (123/155) of patients showed diagnostic concordance of CMD (MRR ≤3.0) across the three vessels.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: In most ANOCA patients, microvascular function is homogeneously distributed across the three major coronary territories. Single-artery testing may suffice in many cases, aligning with guidelines. However, some patients exhibit notable inter-territorial variation, suggesting that multivessel evaluation may be prudent in borderline scenarios.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40126977/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40126977</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf101>10.1093/ehjci/jeaf101</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40126977</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Masahiro Hoshino</dc:creator>
<dc:creator>Roel Hoek</dc:creator>
<dc:creator>Ruurt A Jukema</dc:creator>
<dc:creator>Jorge Dahdal</dc:creator>
<dc:creator>Pepijn van Diemen</dc:creator>
<dc:creator>Pieter Raijmakers</dc:creator>
<dc:creator>Roel Driessen</dc:creator>
<dc:creator>Jos Twisk</dc:creator>
<dc:creator>Ibrahim Danad</dc:creator>
<dc:creator>Tsunekazu Kakuta</dc:creator>
<dc:creator>Juhani Knuuti</dc:creator>
<dc:creator>Paul Knaapen</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>Homogeneity of the Coronary Microcirculation in Angina with Non-Obstructive Coronary Artery Disease</dc:title>
<dc:identifier>pmid:40126977</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf101</dc:identifier>
</item>
<item>
<title>Successful percutaneous retrieval of a detached MitraClip® in the left atrium via maintained gripper line: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124626/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) with MitraClip® has become an established treatment for high-risk patients with mitral regurgitation (MR). While device-related complications are known, they typically occur during leaflet grasping or after deployment, with most issues arising from device-tissue interaction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 8;9(3):ytaf124. doi: 10.1093/ehjcr/ytaf124. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) with MitraClip® has become an established treatment for high-risk patients with mitral regurgitation (MR). While device-related complications are known, they typically occur during leaflet grasping or after deployment, with most issues arising from device-tissue interaction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: A 67-year-old woman with dilated cardiomyopathy underwent M-TEER for severe functional MR. Although resistance was noted during initial device preparation and loading, limited functional testing appeared normal and the procedure was continued. During clip manipulation in the left atrium, mechanical resistance in the arm positioner led to unexpected detachment of the MitraClip, connected only by the gripper line. Through careful traction under echocardiographic and fluoroscopic guidance, we successfully retrieved the clip percutaneously. The procedure was completed with new MitraClip systems, achieving mild residual MR. The patient's symptoms improved from New York Heart Association Classes II and III to I, with sustained improvement during 4.5 years of follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: This case reveals a novel mechanism of MitraClip detachment through mechanical failure during preparation, where introducer damage led to harness deformation and subsequent clip detachment. Among available retrieval options, we demonstrated the feasibility of direct traction retrieval under specific conditions, offering a less invasive solution when gripper line connection is maintained. This case emphasizes the importance of meticulous device inspection and preparation, while providing insights into both failure mechanisms and retrieval strategies in M-TEER complications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124626/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40124626</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11926327/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">PMC11926327</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf124>10.1093/ehjcr/ytaf124</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124626</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Hiroto Yagasaki</dc:creator>
<dc:creator>Takeki Suzuki</dc:creator>
<dc:creator>Ryota Watanabe</dc:creator>
<dc:creator>Keitaro Watanabe</dc:creator>
<dc:creator>Toshiyuki Noda</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Successful percutaneous retrieval of a detached MitraClip® in the left atrium via maintained gripper line: a case report</dc:title>
<dc:identifier>pmid:40124626</dc:identifier>
<dc:identifier>pmc:PMC11926327</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf124</dc:identifier>
</item>
<item>
<title>Percutaneous coronary intervention in anomalous aortic origin of a coronary artery: a rare case report of a dual-left anterior descending artery with a pre-pulmonary course</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124625/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: This case underscores the importance of CT scan in delineating the anatomical characteristics of AAOCA, and the feasibility and efficacy of PCI in symptomatic, non-high-risk AAOCA, emphasizing its role as a minimally invasive alternative within a multidisciplinary approach.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 3;9(3):ytaf112. doi: 10.1093/ehjcr/ytaf112. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Anomalous aortic origin of a coronary artery (AAOCA) of the left anterior descending artery (LAD) is a rare congenital anomaly. Their percutaneous coronary intervention (PCI) when an ischaemia is documented remains challenging.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE PRESENTATION: We report the case of a 52-year-old patient from Bangladesh with dual-origin LAD arising from both left and right sinus with a pre-pulmonary course, presenting with exertional angina and documented myocardial ischaemia. Computed tomography (CT) scan confirmed the anatomical course of the AAOCA. Percutaneous coronary intervention was successfully performed using tailored techniques to treat significant atherosclerotic lesions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This case underscores the importance of CT scan in delineating the anatomical characteristics of AAOCA, and the feasibility and efficacy of PCI in symptomatic, non-high-risk AAOCA, emphasizing its role as a minimally invasive alternative within a multidisciplinary approach.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124625/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40124625</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925849/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">PMC11925849</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf112>10.1093/ehjcr/ytaf112</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124625</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Sara Jourani</dc:creator>
<dc:creator>Zakaria Laraichi</dc:creator>
<dc:creator>Mehdi Saighi Bouaouina</dc:creator>
<dc:creator>Cedric Gaultier</dc:creator>
<dc:creator>Hakim Benamer</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Percutaneous coronary intervention in anomalous aortic origin of a coronary artery: a rare case report of a dual-left anterior descending artery with a pre-pulmonary course</dc:title>
<dc:identifier>pmid:40124625</dc:identifier>
<dc:identifier>pmc:PMC11925849</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf112</dc:identifier>
</item>
<item>
<title>Bachmann's bundle and upper septal inter-atrial connections as key paths for a biatrial macro re-entrant circle: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124624/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: The Bachmann's bundle has been described as a key route for re-entrant circuits in biatrial tachycardias. Septal inter-atrial muscular connections were discovered a while ago, but evidence on their potential role in re-entrant tachycardias is lacking.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 7;9(3):ytaf119. doi: 10.1093/ehjcr/ytaf119. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The Bachmann's bundle has been described as a key route for re-entrant circuits in biatrial tachycardias. Septal inter-atrial muscular connections were discovered a while ago, but evidence on their potential role in re-entrant tachycardias is lacking.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: We describe an atrial macro re-entrant circuit presented as a wide complex tachycardia that utilized the Bachmann's bundle, septal inter-atrial connections, and a limited area of the anterior left atrial myocardium in a patient with previous multiple atrial fibrillation ablation procedures. This tachycardia was diagnosed by using a combination of electrophysiological visualization modalities and was terminated by a single radiofrequency application.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: The inter-atrial muscular connections can pose a major contribution to the mechanism of biatrial tachycardias, especially in patients after extensive left atrial ablation. Thorough mapping modalities, including entrainment stimulation, facilitate a correct diagnosis. Understanding inter-atrial connection anatomy is crucial for the detection and successful ablation of such tachycardia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124624/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40124624</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925846/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">PMC11925846</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf119>10.1093/ehjcr/ytaf119</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124624</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Heber Ivan Condori Leandro</dc:creator>
<dc:creator>Dmitry S Lebedev</dc:creator>
<dc:creator>Lubov B Mitrofanova</dc:creator>
<dc:creator>Evgeny N Mikhaylov</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Bachmann's bundle and upper septal inter-atrial connections as key paths for a biatrial macro re-entrant circle: a case report</dc:title>
<dc:identifier>pmid:40124624</dc:identifier>
<dc:identifier>pmc:PMC11925846</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf119</dc:identifier>
</item>
<item>
<title>Shear wave elastography to unmask differences in myocardial stiffness between athletes and sedentary non-athletes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: SW elastography reveals reduced myocardial stiffness in athletes compared to sedentary non-athletes at rest and during exercise, which is not detected by conventional echocardiographic measurements. Exercise-induced changes in SW velocities after AVC may potentially serve as an early marker for detecting diastolic dysfunction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Imaging Methods Pract. 2025 Mar 21;2(4):qyaf023. doi: 10.1093/ehjimp/qyaf023. eCollection 2024 Oct.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Myocardial stiffening naturally occurs with aging and contributes to diastolic dysfunction. Assessing myocardial stiffness non-invasively could improve the sensitivity of diastolic function evaluation in clinical practice. Shear wave (SW) elastography is a non-invasive tool for quantifying myocardial stiffness, where higher SW velocities indicate increased stiffness. We investigated whether SW elastography could detect differences in myocardial stiffness between athletes and sedentary non-athletes and, during exercise, reveal differences in operational stiffness that may indicate diastolic dysfunction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We enrolled 20 master athletes (median age 60 [IQR 59-66] years) and 17 sedentary non-athletes (median age 58 [IQR 52-71] years). Standard exercise echocardiography revealed no significant differences in diastolic function between the groups. Additionally, ultra-high frame rate imaging was used to measure SW velocities after mitral valve closure (MVC) and aortic valve closure (AVC) at rest and during exercise. At rest, athletes had lower SW velocities after MVC compared to sedentary non-athletes (3.2 ± 0.4 m/s vs. 3.9 ± 0.7 m/s, respectively, <i>P</i> = 0.003). During exercise, SW velocities after AVC significantly increased in sedentary non-athletes but not in athletes (+1.6 ± 1.6 cm/s increase per 1% power output increase vs. 0.0 ± 0.8 cm/s, respectively, <i>P</i> = 0.006). An inverse correlation was found between the increase of SW velocity after AVC during exercise and VO<sub>2</sub>max (<i>r</i> = -0.51, <i>P</i> = 0.003).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: SW elastography reveals reduced myocardial stiffness in athletes compared to sedentary non-athletes at rest and during exercise, which is not detected by conventional echocardiographic measurements. Exercise-induced changes in SW velocities after AVC may potentially serve as an early marker for detecting diastolic dysfunction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40124097</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925635/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">PMC11925635</a> | DOI:<a href=https://doi.org/10.1093/ehjimp/qyaf023>10.1093/ehjimp/qyaf023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124097</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Karim Taha</dc:creator>
<dc:creator>Youri Bekhuis</dc:creator>
<dc:creator>Ruben de Bosscher</dc:creator>
<dc:creator>Christophe Dausin</dc:creator>
<dc:creator>Marta Orlowska</dc:creator>
<dc:creator>Ahmed S Youssef</dc:creator>
<dc:creator>Stéphanie Bézy</dc:creator>
<dc:creator>Véronique Cornelissen</dc:creator>
<dc:creator>Lieven Herbots</dc:creator>
<dc:creator>Rik Willems</dc:creator>
<dc:creator>Jens-Uwe Voigt</dc:creator>
<dc:creator>Jan D'hooge</dc:creator>
<dc:creator>Guido Claessen</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Imaging methods and practice</dc:source>
<dc:title>Shear wave elastography to unmask differences in myocardial stiffness between athletes and sedentary non-athletes</dc:title>
<dc:identifier>pmid:40124097</dc:identifier>
<dc:identifier>pmc:PMC11925635</dc:identifier>
<dc:identifier>doi:10.1093/ehjimp/qyaf023</dc:identifier>
</item>
<item>
<title>Focus on old and emerging risk factors: familial hypercholesterolaemia, lipoprotein(a), and skeletal muscle adiposity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123524/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 24;46(12):1083-1087. doi: 10.1093/eurheartj/ehaf124.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123524/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123524</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf124>10.1093/eurheartj/ehaf124</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123524</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on old and emerging risk factors: familial hypercholesterolaemia, lipoprotein(a), and skeletal muscle adiposity</dc:title>
<dc:identifier>pmid:40123524</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf124</dc:identifier>
</item>
<item>
<title>Antispasmodic Medications to Optimize Long-Term Radial Artery Graft Patency in CABG</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123510/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 24:e015199. doi: 10.1161/CIRCINTERVENTIONS.125.015199. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123510/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123510</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.125.015199>10.1161/CIRCINTERVENTIONS.125.015199</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123510</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Dominique Vervoort</dc:creator>
<dc:creator>Stephen E Fremes</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>Antispasmodic Medications to Optimize Long-Term Radial Artery Graft Patency in CABG</dc:title>
<dc:identifier>pmid:40123510</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.125.015199</dc:identifier>
</item>
<item>
<title>Utility of 3D Intracardiac Echocardiography in TriClip: A Future Without Transesophageal Echocardiography?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123502/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Imaging. 2025 Mar 24:e017738. doi: 10.1161/CIRCIMAGING.124.017738. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123502/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123502</a> | DOI:<a href=https://doi.org/10.1161/CIRCIMAGING.124.017738>10.1161/CIRCIMAGING.124.017738</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123502</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Fei Yu</dc:creator>
<dc:creator>Scott Dougherty</dc:creator>
<dc:creator>Kent Chak-Yu So</dc:creator>
<dc:creator>Kevin Ka-Ho Kam</dc:creator>
<dc:creator>Chenxu Zhao</dc:creator>
<dc:creator>Xinghua Shan</dc:creator>
<dc:creator>Alex Pui-Wai Lee</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular imaging</dc:source>
<dc:title>Utility of 3D Intracardiac Echocardiography in TriClip: A Future Without Transesophageal Echocardiography?</dc:title>
<dc:identifier>pmid:40123502</dc:identifier>
<dc:identifier>doi:10.1161/CIRCIMAGING.124.017738</dc:identifier>
</item>
<item>
<title>Improving Cardiovascular Health Through the Consideration of Social Factors in Genetics and Genomics Research: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123498/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>Cardiovascular health (CVH) is affected by genetic, social, and genomic factors across the life course, yet little research has focused on the interrelationships among them. An extensive body of work has documented the impact of social determinants of health at both the structural and individual levels on CVH, highlighting pathways in which racism, housing, violence, and neighborhood environments adversely affect CVH and contribute to disparities in cardiovascular disease. Genetic factors have...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Qual Outcomes. 2025 Mar 24:e000138. doi: 10.1161/HCQ.0000000000000138. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular health (CVH) is affected by genetic, social, and genomic factors across the life course, yet little research has focused on the interrelationships among them. An extensive body of work has documented the impact of social determinants of health at both the structural and individual levels on CVH, highlighting pathways in which racism, housing, violence, and neighborhood environments adversely affect CVH and contribute to disparities in cardiovascular disease. Genetic factors have also been identified as contributors to risk for cardiovascular disease. Emerging evidence suggests that social factors can interact with genetic susceptibility to affect disease risk. Increasingly, social factors have been shown to affect epigenetic markers such as DNA methylation, which can regulate gene and protein expression. This is a potential biological mechanism through which exposure to poor social determinants of health becomes physically embodied at the molecular level, potentially contributing to the development of suboptimal CVH and chronic disease, thus reinforcing and propagating health disparities. The objective of this statement is to highlight and summarize key literature that has examined the joint associations between social, genetic, and genomic factors and CVH and cardiovascular disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123498/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123498</a> | DOI:<a href=https://doi.org/10.1161/HCQ.0000000000000138>10.1161/HCQ.0000000000000138</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123498</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Shakira F Suglia</dc:creator>
<dc:creator>Bertha Hidalgo</dc:creator>
<dc:creator>Andrea A Baccarelli</dc:creator>
<dc:creator>Andres Cardenas</dc:creator>
<dc:creator>Scott Damrauer</dc:creator>
<dc:creator>Amber Johnson</dc:creator>
<dc:creator>Kaitlin Key</dc:creator>
<dc:creator>Mingyu Liang</dc:creator>
<dc:creator>Jared W Magnani</dc:creator>
<dc:creator>Brittany Pate</dc:creator>
<dc:creator>Mario Sims</dc:creator>
<dc:creator>Gabriel S Tajeu</dc:creator>
<dc:creator>American Heart Association Social Determinants of Health Committee of the Council on Epidemiology and Prevention and Council on Quality of Care and Outcomes Research; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; Council on Hypertension; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular quality and outcomes</dc:source>
<dc:title>Improving Cardiovascular Health Through the Consideration of Social Factors in Genetics and Genomics Research: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:40123498</dc:identifier>
<dc:identifier>doi:10.1161/HCQ.0000000000000138</dc:identifier>
</item>
<item>
<title>Determinants and Prognostic Value of Early Gadolinium Enhancement-Derived Myocardial Salvage Index in STEMI</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123493/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: EGE-derived MSI was associated with prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow and microvascular injuries. It was an independent predictor of major adverse cardiac events. Our results highlight the prognostic potential of EGE imaging in acute myocardial infarction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Imaging. 2025 Mar 24:e017830. doi: 10.1161/CIRCIMAGING.124.017830. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: T2-weighted imaging is commonly used to measure myocardial salvage in reperfused myocardial infarction but is hindered by poor reproducibility and indistinct boundaries. Early gadolinium enhancement (EGE) emerges as an alternative for measuring the area at risk. This study aims to evaluate the determinants of the myocardial salvage index (MSI) derived from EGE and its prognostic implications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We analyzed acute cardiac magnetic resonance scans of 453 reperfused patients with ST-segment-elevation myocardial infarction (mean age, 60±12 years; 389 men) from April 2017 to July 2023 at a single center retrospectively. EGE was collected at 3 minutes after contrast agent injection, where hyperintense areas (signal intensities >; mean+2SD of remote myocardium) were considered as the area at risk, plus the hypointense core within. MSI was calculated as the ratio of salvageable myocardium to the area at risk. Major adverse cardiovascular events included cardiovascular death, hospitalization for heart failure, reinfarction, and unplanned revascularization for the target vessel.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: During a median follow-up of 3.2 years (interquartile range, 1.6-4.7 years), at least one major adverse cardiac event occurred in 91 participants (20.1%). The median MSI was 35.0% (interquartile range, 22.9-59.5%), with smaller MSI observed in patients with larger infarcts (<i>P</i>&lt;0.001). Linear regression identified prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow (β=3.35, <i>P</i>&lt;0.001) and microvascular obstruction (β=-11.92, <i>P</i>&lt;0.001) as independent determinants of MSI. Multivariable Cox regression showed that every 10% increase in MSI was associated with a 32% reduction in major adverse cardiac event risk (hazard ratio, 0.68 [95% CI, 0.53-0.86]; <i>P</i>=0.001). A graded response was observed between MSI and cardiovascular death and reinfarction. MSI greater than the median was associated with nontarget vessel-related reinfarctions but not target vessel-related ones (nontarget, <i>P</i>=0.027; target vessel, <i>P</i>=0.36). Good reproducibility was reported with EGE-measured area at risk (intraobserver, intraclass correlation coefficient [ICC]=0.95; interobserver, ICC=0.89).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: EGE-derived MSI was associated with prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow and microvascular injuries. It was an independent predictor of major adverse cardiac events. Our results highlight the prognostic potential of EGE imaging in acute myocardial infarction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123493/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123493</a> | DOI:<a href=https://doi.org/10.1161/CIRCIMAGING.124.017830>10.1161/CIRCIMAGING.124.017830</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123493</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jin-Yi Xiang</dc:creator>
<dc:creator>Jin-Yu Zheng</dc:creator>
<dc:creator>Yi-Si Dai</dc:creator>
<dc:creator>Ling-Yi Yu</dc:creator>
<dc:creator>Yu-Fan Qian</dc:creator>
<dc:creator>Wei-Hui Xie</dc:creator>
<dc:creator>Ruo-Yang Shi</dc:creator>
<dc:creator>Bing-Hua Chen</dc:creator>
<dc:creator>Jun Pu</dc:creator>
<dc:creator>Lian-Ming Wu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular imaging</dc:source>
<dc:title>Determinants and Prognostic Value of Early Gadolinium Enhancement-Derived Myocardial Salvage Index in STEMI</dc:title>
<dc:identifier>pmid:40123493</dc:identifier>
<dc:identifier>doi:10.1161/CIRCIMAGING.124.017830</dc:identifier>
</item>
<item>
<title>Effects of Nicorandil, Isosorbide Mononitrate, or Diltiazem on Radial Artery Grafts After CABG: The Randomized ASRAB-Pilot Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123490/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In this pilot trial, treatment with nicorandil or isosorbide mononitrate was associated with a lower RA graft failure rate compared with diltiazem. Larger hypothesis-testing trials are warranted.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 24:e014542. doi: 10.1161/CIRCINTERVENTIONS.124.014542. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The optimal antispastic treatment after coronary artery bypass grafting using radial artery (RA) grafts is controversial. This clinical trial aimed to generate pilot comparative data on the effects of nicorandil, isosorbide mononitrate, or diltiazem on RA grafts.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a single-center, randomized, open-label, parallel-group pilot trial. Eligible patients who underwent coronary artery bypass grafting using RA grafts were randomized in a 1:1:1 ratio to receive oral nicorandil (15 mg daily), isosorbide mononitrate (50 mg daily), or diltiazem (180 mg daily) for 24 weeks post-coronary artery bypass grafting. The primary outcome was RA graft failure (modified Fitzgibbon grade B, S, or O) at 1 and 24 weeks, assessed by coronary computed tomography angiography.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 150 randomized participants, 149 (mean age, 56.8 years; 13.4% women) with 177 RA grafts were assessed at least once by coronary computed tomography angiography, including 50 participants with 64 RA grafts in the nicorandil group, 50 participants with 57 RA grafts in the isosorbide mononitrate group, and 49 participants with 56 RA grafts in the diltiazem group, respectively. At 1 week post-coronary artery bypass grafting, the RA graft failure rates were lower with nicorandil versus diltiazem (19.4% versus 25.0%; difference, -5.6% [95% CI, -20.6% to 9.3%]) and isosorbide mononitrate versus diltiazem (18.2% versus 25.0%; difference, -6.8% [95% CI, -21.8% to 8.6%]). The RA graft failure rates were slightly higher with nicorandil versus isosorbide mononitrate (19.4% versus 18.2%; difference, 1.2% [95% CI, -13.3% to 15.2%]). At 24 weeks, RA graft failure rates were lower with nicorandil versus diltiazem (16.1% versus 27.8%; difference, -11.7% [95% CI, -26.6% to 3.4%]), and isosorbide mononitrate versus diltiazem (12.5% versus 27.8%; difference, -15.3% [95% CI, -29.8% to -0.2%]), and slightly higher with nicorandil versus isosorbide mononitrate (16.1% versus 12.5%; difference, 3.6% [95% CI, -9.6% to 16.4%]).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In this pilot trial, treatment with nicorandil or isosorbide mononitrate was associated with a lower RA graft failure rate compared with diltiazem. Larger hypothesis-testing trials are warranted.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04310995.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123490/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123490</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014542>10.1161/CIRCINTERVENTIONS.124.014542</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123490</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Yunpeng Zhu</dc:creator>
<dc:creator>Wei Zhang</dc:creator>
<dc:creator>Kaijie Qin</dc:creator>
<dc:creator>Yun Liu</dc:creator>
<dc:creator>Haoyi Yao</dc:creator>
<dc:creator>Zhe Wang</dc:creator>
<dc:creator>Xiaofeng Ye</dc:creator>
<dc:creator>Mi Zhou</dc:creator>
<dc:creator>Haiqing Li</dc:creator>
<dc:creator>Jiapei Qiu</dc:creator>
<dc:creator>Hong Xu</dc:creator>
<dc:creator>Yanjun Sun</dc:creator>
<dc:creator>Mario Gaudino</dc:creator>
<dc:creator>Qiang Zhao</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>Effects of Nicorandil, Isosorbide Mononitrate, or Diltiazem on Radial Artery Grafts After CABG: The Randomized ASRAB-Pilot Trial</dc:title>
<dc:identifier>pmid:40123490</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.124.014542</dc:identifier>
</item>
<item>
<title>How to Improve Radiation Protection in Interventional Cardiology Procedures</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123489/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325061242&amp;v=2.18.0.post9+e462414
      <description>The use of ionizing radiation during cardiac catheterization procedures poses risks to patients and medical staff, both directly and indirectly through orthopedic injuries caused by lead aprons. In this review, we summarize recent advances in radiation protection in the cardiac catheterization laboratory and discuss the effectiveness of traditional and novel radiation protection strategies and equipment.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 24:e014808. doi: 10.1161/CIRCINTERVENTIONS.124.014808. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The use of ionizing radiation during cardiac catheterization procedures poses risks to patients and medical staff, both directly and indirectly through orthopedic injuries caused by lead aprons. In this review, we summarize recent advances in radiation protection in the cardiac catheterization laboratory and discuss the effectiveness of traditional and novel radiation protection strategies and equipment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123489/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325061242&v=2.18.0.post9+e462414">40123489</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014808>10.1161/CIRCINTERVENTIONS.124.014808</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123489</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Dimitrios Strepkos</dc:creator>
<dc:creator>Athanasios Rempakos</dc:creator>
<dc:creator>Michaella Alexandrou</dc:creator>
<dc:creator>Deniz Mutlu</dc:creator>
<dc:creator>Pedro E P Carvalho</dc:creator>
<dc:creator>Ali Bahbah</dc:creator>
<dc:creator>Ryan D Madder</dc:creator>
<dc:creator>Simon R Dixon</dc:creator>
<dc:creator>Anastasios Milkas</dc:creator>
<dc:creator>Kevin J Croce</dc:creator>
<dc:creator>William J Nicholson</dc:creator>
<dc:creator>Lorenzo Azzalini</dc:creator>
<dc:creator>Bavana V Rangan</dc:creator>
<dc:creator>Olga C Mastrodemos</dc:creator>
<dc:creator>Konstantinos Voudris</dc:creator>
<dc:creator>Ahmed Al-Ogaili</dc:creator>
<dc:creator>M Nicholas Burke</dc:creator>
<dc:creator>Yader Sandoval</dc:creator>
<dc:creator>Emmanouil S Brilakis</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>How to Improve Radiation Protection in Interventional Cardiology Procedures</dc:title>
<dc:identifier>pmid:40123489</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.124.014808</dc:identifier>
</item>





























</channel>
</rss>